These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

340 related items for PubMed ID: 25625579

  • 1. Circulating microRNAs as noninvasive diagnostic biomarkers of liver disease in children with cystic fibrosis.
    Cook NL, Pereira TN, Lewindon PJ, Shepherd RW, Ramm GA.
    J Pediatr Gastroenterol Nutr; 2015 Feb; 60(2):247-54. PubMed ID: 25625579
    [Abstract] [Full Text] [Related]

  • 2. MicroRNA Sequencing Identifies a Serum MicroRNA Panel, Which Combined With Aspartate Aminotransferase to Platelet Ratio Index Can Detect and Monitor Liver Disease in Pediatric Cystic Fibrosis.
    Calvopina DA, Chatfield MD, Weis A, Coleman MA, Fernandez-Rojo MA, Noble C, Ramm LE, Leung DH, Lewindon PJ, Ramm GA.
    Hepatology; 2018 Dec; 68(6):2301-2316. PubMed ID: 30014495
    [Abstract] [Full Text] [Related]

  • 3. Serum markers of hepatic fibrogenesis in cystic fibrosis liver disease.
    Pereira TN, Lewindon PJ, Smith JL, Murphy TL, Lincoln DJ, Shepherd RW, Ramm GA.
    J Hepatol; 2004 Oct; 41(4):576-83. PubMed ID: 15464237
    [Abstract] [Full Text] [Related]

  • 4. Aspartate aminotransferase to platelet ratio and fibrosis-4 as biomarkers in biopsy-validated pediatric cystic fibrosis liver disease.
    Leung DH, Khan M, Minard CG, Guffey D, Ramm LE, Clouston AD, Miller G, Lewindon PJ, Shepherd RW, Ramm GA.
    Hepatology; 2015 Nov; 62(5):1576-83. PubMed ID: 26223427
    [Abstract] [Full Text] [Related]

  • 5. Gamma-glutamyl transpeptidase-to-platelet ratio as a biomarker of liver disease and hepatic fibrosis severity in paediatric Cystic Fibrosis.
    Calvopina DA, Lewindon PJ, Ramm LE, Noble C, Hartel GF, Leung DH, Ramm GA.
    J Cyst Fibros; 2022 Mar; 21(2):236-242. PubMed ID: 34953741
    [Abstract] [Full Text] [Related]

  • 6. Transcriptional basis for hepatic fibrosis in cystic fibrosis-associated liver disease.
    Pereira TN, Lewindon PJ, Greer RM, Hoskins AC, Williamson RM, Shepherd RW, Ramm GA.
    J Pediatr Gastroenterol Nutr; 2012 Mar; 54(3):328-35. PubMed ID: 22157922
    [Abstract] [Full Text] [Related]

  • 7. Supersonic shear-wave elastography and APRI for the detection and staging of liver disease in pediatric cystic fibrosis.
    Calvopina DA, Noble C, Weis A, Hartel GF, Ramm LE, Balouch F, Fernandez-Rojo MA, Coleman MA, Lewindon PJ, Ramm GA.
    J Cyst Fibros; 2020 May; 19(3):449-454. PubMed ID: 31303380
    [Abstract] [Full Text] [Related]

  • 8. Accuracy of Transient Elastography Data Combined With APRI in Detection and Staging of Liver Disease in Pediatric Patients With Cystic Fibrosis.
    Lewindon PJ, Puertolas-Lopez MV, Ramm LE, Noble C, Pereira TN, Wixey JA, Hartel GF, Calvopina DA, Leung DH, Ramm GA.
    Clin Gastroenterol Hepatol; 2019 Nov; 17(12):2561-2569.e5. PubMed ID: 30880274
    [Abstract] [Full Text] [Related]

  • 9. Endogenous ursodeoxycholic acid and cholic acid in liver disease due to cystic fibrosis.
    Smith JL, Lewindon PJ, Hoskins AC, Pereira TN, Setchell KD, O'Connell NC, Shepherd RW, Ramm GA.
    Hepatology; 2004 Jun; 39(6):1673-82. PubMed ID: 15185309
    [Abstract] [Full Text] [Related]

  • 10. Serum MicroRNAs as Potential Biomarkers for Early Diagnosis of Hepatitis C Virus-Related Hepatocellular Carcinoma in Egyptian Patients.
    Motawi TK, Shaker OG, El-Maraghy SA, Senousy MA.
    PLoS One; 2015 Jun; 10(9):e0137706. PubMed ID: 26352740
    [Abstract] [Full Text] [Related]

  • 11. Serum microRNAs as predictors for liver fibrosis staging in hepatitis C virus-associated chronic liver disease patients.
    Shaker OG, Senousy MA.
    J Viral Hepat; 2017 Aug; 24(8):636-644. PubMed ID: 28211229
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of noninvasive markers for the diagnosis of cystic fibrosis liver disease.
    Alexopoulou A, Pouriki S, Vasilieva L, Alexopoulos T, Filaditaki V, Gioka M, Diamantea F, Dourakis SP.
    Scand J Gastroenterol; 2018 Dec; 53(12):1547-1552. PubMed ID: 30600723
    [Abstract] [Full Text] [Related]

  • 13. A plasma microRNA panel for detection of colorectal adenomas: a step toward more precise screening for colorectal cancer.
    Kanaan Z, Roberts H, Eichenberger MR, Billeter A, Ocheretner G, Pan J, Rai SN, Jorden J, Williford A, Galandiuk S.
    Ann Surg; 2013 Sep; 258(3):400-8. PubMed ID: 24022433
    [Abstract] [Full Text] [Related]

  • 14. Serum proteome profiling identifies novel and powerful markers of cystic fibrosis liver disease.
    Rath T, Hage L, Kügler M, Menendez Menendez K, Zachoval R, Naehrlich L, Schulz R, Roderfeld M, Roeb E.
    PLoS One; 2013 Sep; 8(3):e58955. PubMed ID: 23516586
    [Abstract] [Full Text] [Related]

  • 15. A serum microRNA classifier for early detection of hepatocellular carcinoma: a multicentre, retrospective, longitudinal biomarker identification study with a nested case-control study.
    Lin XJ, Chong Y, Guo ZW, Xie C, Yang XJ, Zhang Q, Li SP, Xiong Y, Yuan Y, Min J, Jia WH, Jie Y, Chen MS, Chen MX, Fang JH, Zeng C, Zhang Y, Guo RP, Wu Y, Lin G, Zheng L, Zhuang SM.
    Lancet Oncol; 2015 Jul; 16(7):804-15. PubMed ID: 26088272
    [Abstract] [Full Text] [Related]

  • 16. Circulating microRNAs as biomarkers for diffuse myocardial fibrosis in patients with hypertrophic cardiomyopathy.
    Fang L, Ellims AH, Moore XL, White DA, Taylor AJ, Chin-Dusting J, Dart AM.
    J Transl Med; 2015 Sep 24; 13():314. PubMed ID: 26404540
    [Abstract] [Full Text] [Related]

  • 17. A longitudinal assessment of non-invasive biomarkers to diagnose and predict cystic fibrosis-associated liver disease.
    Karnsakul W, Wasuwanich P, Ingviya T, Vasilescu A, Carson KA, Mogayzel PJ, Schwarz KB.
    J Cyst Fibros; 2020 Jul 24; 19(4):546-552. PubMed ID: 32482593
    [Abstract] [Full Text] [Related]

  • 18. Discovery and validation of extracellular/circulating microRNAs during idiopathic pulmonary fibrosis disease progression.
    Yang G, Yang L, Wang W, Wang J, Wang J, Xu Z.
    Gene; 2015 May 10; 562(1):138-44. PubMed ID: 25725128
    [Abstract] [Full Text] [Related]

  • 19. Circulating microRNAs as a marker for liver injury in human immunodeficiency virus patients.
    Anadol E, Schierwagen R, Elfimova N, Tack K, Schwarze-Zander C, Eischeid H, Noetel A, Boesecke C, Jansen C, Dold L, Wasmuth JC, Strassburg CP, Spengler U, Rockstroh JK, Odenthal M, Trebicka J.
    Hepatology; 2015 Jan 10; 61(1):46-55. PubMed ID: 25125218
    [Abstract] [Full Text] [Related]

  • 20. Analysis of a large cohort of cystic fibrosis patients with severe liver disease indicates lung function decline does not significantly differ from that of the general cystic fibrosis population.
    Polineni D, Piccorelli AV, Hannah WB, Dalrymple SN, Pace RG, Durie PR, Ling SC, Knowles MR, Stonebraker JR.
    PLoS One; 2018 Jan 10; 13(10):e0205257. PubMed ID: 30307979
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.